Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Gary D. Glick0
Shomir Ghosh0
William R. Roush0
Date of Patent
January 14, 2020
Patent Application Number
16094000
Date Filed
April 19, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that modulate (e.g., agonize or partially agonize) NLRP3 and TLR7 and/or TLR8 that are useful, e.g., for treating a condition, disease or disorder in which a decrease in NLRP3 and TLR7 and/or TLR8 activities (e.g., a condition, disease or disorder associated with repressed or impaired NLRP3 and TLR7 and/or TLR8 signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions as well as other methods of using and making the same.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.